Noxilizer’s Evan Goulet and Stephen Morley outline the advantages that nitrogen dioxide (NO2) technology is able to provide over more traditional methods in the sterilisation of prefilled syringes
Sterilisation of prefilled syringes today is predominantly accomplished using steam, EO or gamma radiation. While these methods are well established, their limitations could impede innovation and progress in the pharmaceutical and biotechnology industries. More than 60% of new drug products being developed today are biologics, such as protein therapies[1]. This rapid rise in biological drug development is expanding the market for new sterilisation technologies that can overcome the limitations of current methods.